LA JOLLA, CA—New research shows how genetic variations linked to severe cases of COVID-19 affect our immune cells. Credit: La Jolla Institute for Immunology LA JOLLA,...
Kathryn Corzo Kathryn Corzo — an oncology veteran and the program head behind Sanofi’s multiple myeloma monoclonal antibody isatuximab — is now in the C-suite. The...
The PD-1 blocker market has exploded into place as one of the most important and promising major biopharma oncology markets yet to appear. Immuno-oncology drugs that...
A virtual reality system developed by AppliedVR that has been shown in trials to help reduce chronic lower The post AppliedVR’s virtual reality therapy for pain...
Western medicine has always split the mind and the body. Long COVID reveals just how damaging this approach has been.
GEN’s updated A-List of top companies in RNA-based biotech, encompassing not only developers of vaccines and drugs based on various forms of RNA, but developers of...
Pharmaceutical companies work towards bringing new cures to the market and improving treatments available for patients. The post Investing in Pharmaceutical Companies appeared first on Investing...
Reps. Fred Upton (R-MI) and Diana DeGette (D-CO) on Tuesday unveiled the second iteration of their mammoth 21st Century Cures Act, a wide-ranging, mostly pro-pharma law...
Weeks after unveiling positive Phase IIb data, PhaseBio Pharmaceuticals announced positive interim Phase III data demonstrating the ability of the company's lead product candidate bentracimab to...
These health care industry players continue to serve the masses amid the current pandemic. The post Hot Stocks To Buy Now? 4 Health Care Stocks To...
In COVID-19 patients, obesity is the factor most associated with the development of endothelial dysfunction, a condition in which the blood vessels become unable to contract...
Britain's GSK and partner Vir Biotechnology said on November 12 their antibody-based Covid-19 drug was shown in a trial to work as well when given as...
Having sent 1.5 billion Covid-19 vaccines around the world on a not-for-profit basis, AstraZeneca says it’s time to move into “modest profitability.” While the priority is...
The EMA’s human medicines committee has recommended approval of Roche’s Ronapreve and Celltrion’s Regkirona for use in COVID-19, The post COVID antibodies from Roche, Celltrion backed...
AstraZeneca has said it plans to start making a small profit from sales of its COVID-19 vaccine Vaxzevria, The post AstraZeneca will make ‘modest’ profit from...
Check these penny stocks out for your watchlist in November The post Are These Penny Stocks Worth Being Bullish On? 3 to Watch appeared first on...
The US federal government has ordered another 1.4 million doses of Merck & Co and Ridgeback Biotherapeutics’ oral The post US buys another $1 billion-worth of...
In a groundbreaking study of people living with HIV, University of Alberta researchers found that elusive white blood cells called neutrophils play a role in impaired...
Novotech, a leading biotech specialist CRO in the Asia-Pacific region, is sponsoring the ChinaTrials13 conference and will have teams from Novotech’s China offices attending to support...
Roblox Corp (NYSE: RBLX) shares jumped 30% after hours on Monday after the company posted robust fiscal Q3 results thanks to demand surge with the easing...
Regeneron Pharmaceuticals Inc. said on November 8 a single dose of the company's antibody cocktail reduced the risk of contracting Covid-19 by 81.6 percent in a...
A single dose of the COVID-19 monoclonal antibody therapy developing Regeneron reduced the risk of contracting the virus The post One dose of Regeneron’s COVID antibody...
5 short squeeze penny stocks to buy for under $5. Are they worth the risk? The post 5 Short Squeeze Penny Stocks To Buy For Under...
Pfizer plans to seek Emergency Use Authorization (EUA) for an antiviral Covid-19 treatment following an interim analysis of Phase II/III data shown to be statistically and...
Recouping from a series of setbacks for its gene therapy business, bluebird bio successfully bisected itself earlier this week as part of a big rebrand around...
Merck & Co and Ridgeback’s oral antiviral molnupiravir has been approved in its first market – the UK The post UK first to authorise Merck/Ridgeback’s COVID...
A real-world study of digital therapeutic (DTx) for opioid use disorder has found that patient show used it The post Digital therapeutic cuts opioid use disorder...
Rocketing sales of COVID-19 vaccine Comirnaty have allowed Pfizer to raise its full-year forecasts for the shot once The post Pfizer’s COVID jab sales swell again,...
Eli Lilly said on Nov. 2 that the U.S. government bought 614,000 additional doses of the company's Covid-19 antibody therapy for $1.29 billion.
Moderna has always been thinking about how mRNA could transform the gene editing space, according to Eric Huang. In fact, they looked at it about a...